City

Montreal (1)

New York (1)

Toronto (1)

Condition

Atherosclerotic Vascular Disease (2)

Microvascular Dysfunction (1)

Type2 Diabetes (1)

Overall Status

Completed (2)

Sign in for free

Phase

phase 2 (1)

phase 4 (1)

Sponsor

Montreal Heart Institute (1)

Robert Rosenson (1)

Collaborator

Amgen (1)

University of Michigan (1)

University of Toronto (1)

Intervention

placebo (2)

colchicine (1)

evolocumab (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

atherosclerotic vascular disease

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Atherosclerotic Vascular Disease, Type2 Diabetes, Microvascular Dysfunction Trial in New York, Toronto (Placebo, Evolocumab)

Completed

Atherosclerotic Vascular Disease
+2 more

Placebo
Evolocumab

New York, New York
+1 more

Jul 11, 2022

Atherosclerotic Vascular Disease Trial in Montreal (Colchicine, Placebo)

Completed

Atherosclerotic Vascular Disease

Colchicine
Placebo

Montreal, Quebec, Canada

Montreal Heart Institute

Feb 20, 2020